ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC

Shares of Synergy Pharmaceuticals Inc. (SGYP) were up over 5% in extended trading on Thursday, following FDA approval of TRULANCE for the treatment of adults with chronic idiopathic constipation.

from RTT - Biotech http://ift.tt/2jFvtcE
via IFTTT